Cardinal Health: Improving Sales Performance with Data Blending and Advanced Analytics
Expiring patents, increasing drug development costs, outcome-based reimbursement models and more stringent regulations are all driving life sciences companies to reassess their business models and rethink their approaches to R&D, pricing, and sales & marketing. Pharma and biotech executives looking for ways to reduce costs, improve efficiency, and mitigate risks, are leaning on already overwhelmed IT departments for faster, more reliable evidence-based insights.
Alteryx can help life sciences companies gain deeper insights by providing line-of-business analysts in R&D, sales, marketing, regulatory affairs, and more, the ability to blend and analyze data themselves, without any coding or IT dependence.
With data blending and analytics from Alteryx, business analysts in pharma and biotech companies can: